The Cell & Gene Therapy Manufacturing Services Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Global Cell & Gene Therapy Manufacturing Services Market has experienced a significant growth trend historically. The market size increased rapidly from $8.15 billion in 2024 to $9.46 billion in 2025. This growth represents a compound annual growth rate (CAGR) of 16.1%.
By 2029, the cell & gene therapy manufacturing services market is forecasted to reach a size of $17.97 billion, growing at a compound annual growth rate (CAGR) of 17.4%.
Download Your Free Sample of the 2025 Cell & Gene Therapy Manufacturing Services Market Report and Uncover Key Trends Now!The key drivers in the cell & gene therapy manufacturing services market are:
• Market maturation and commercialization of cell & gene therapy manufacturing services
• Global expansion of biopharmaceutical manufacturing
• Increased outsourcing by pharmaceutical companies in the sector
• Advancements in automation and robotics in the industry
The cell & gene therapy manufacturing services market covered in this report is segmented –
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
The key trends in the cell & gene therapy manufacturing services market are:
• Global expansion of biopharmaceutical manufacturing is a key trend.
• Increased outsourcing by pharmaceutical companies is driving market trends.
• Advancements in automation and robotics are shaping the future of the market.
• The emergence of new therapeutic modalities is a significant emerging trend.
The major players in the cell & gene therapy manufacturing services market are:
• Thermo Fisher Scientific Inc
North America was the largest region in the cell and gene therapy manufacturing services market in 2024